Cite
HARVARD Citation
Casas, L. et al. (n.d.). OP0059 Golimumab versus tocilizumab for severe and refractory juvenile idiopathic arthritis-uveitis. multicenter study of 33 patients. Annals of the rheumatic diseases. pp. 75-76. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Casas, L. et al. (n.d.). OP0059 Golimumab versus tocilizumab for severe and refractory juvenile idiopathic arthritis-uveitis. multicenter study of 33 patients. Annals of the rheumatic diseases. pp. 75-76. [Online].